|
Volumn 2, Issue 3, 2002, Pages 148-151
|
Implications of pharmacogenomics in oral health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALCOHOL;
ALDOSTERONE;
CAFFEINE;
CANNABIS;
CARBAMAZEPINE;
COCAINE;
COTININE;
ESTROGEN DERIVATIVE;
HYDROCORTISONE;
INSULIN;
LITHIUM;
MELATONIN;
METHADONE;
OPIATE DERIVATIVE;
PHENYTOIN;
PROGESTERONE;
TESTOSTERONE;
THEOPHYLLINE;
ARTICLE;
CONTROLLED STUDY;
DENTAL CARIES;
DENTAL HEALTH;
DNA DAMAGE;
GENE MUTATION;
GENETIC PREDISPOSITION;
GENETIC RISK;
GENOTYPE;
GINGIVA DISEASE;
HEALTH CARE;
HUMAN;
MOUTH CANCER;
MOUTH FLORA;
ONCOGENE;
PERIODONTITIS;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
PROTEOMICS;
SINGLE NUCLEOTIDE POLYMORPHISM;
TOOTH BRUSHING;
TOOTH DISEASE;
BIOTECHNOLOGY;
COMPUTATIONAL BIOLOGY;
HUMANS;
MOUTH DISEASES;
ORAL HEALTH;
PHARMACOGENETICS;
UNITED STATES;
CANNABIS;
|
EID: 0036361034
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500107 Document Type: Article |
Times cited : (3)
|
References (18)
|